Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Non-Current Deferred Tax Liability (2016)

Aptevo Therapeutics' Non-Current Deferred Tax Liability history spans 2 years, with the latest figure at $15.8 million for Q2 2016.

  • For Q2 2016, Non-Current Deferred Tax Liability changed N/A year-over-year to $15.8 million; the TTM value through Jun 2016 reached $15.8 million, changed N/A, while the annual FY2015 figure was $15.8 million, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability for Q2 2016 was $15.8 million at Aptevo Therapeutics, roughly flat from $15.8 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $15.8 million in Q4 2015 and bottomed at $15.8 million in Q4 2015.